Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» non-Hodgkin's lymphoma
non-Hodgkin's lymphoma
Interim Data From Phase 1 Dose Escalation Clinical Trial of TGR-1202, the Once-Daily PI3K Delta Inhibitor, Demonstrates Significant Clinical Activity and Lack of Hepatic Toxicity in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Non-H
Yahoo/Globe NewsWire
Sun, 12/7/14 - 10:04 am
TGR-1202
chronic lymphocytic leukemia
non-Hodgkin's lymphoma
TG Therapeutics
Seattle Genetics Presents Data from SGN-CD19A Antibody-Drug Conjugate at ASH Annual Meeting
Yahoo/BusinessWire
Sun, 12/7/14 - 09:28 am
Seattle Genetics
SGN-CD19A
acute lymphoblastic leukemia
leukemia
non-Hodgkin's lymphoma
diffuse large B-cell lymphoma
JNJ launches PhII lymphoma study for daratumumab
Fierce Biotech
Thu, 12/4/14 - 04:13 pm
JNJ
lymphoma
daratumumab
Genmab
non-Hodgkin's lymphoma
Millennium drug Velcade approved for wider use in the US
Boston Globe, MA
Fri, 10/10/14 - 09:53 am
Velcade
Millennium Pharmaceuticals
non-Hodgkin's lymphoma
Takeda
Janssen
Seattle Genetics Presents Data from Phase 1 Clinical Trial of Antibody-Drug Conjugate (ADC) SGN-CD19A in Non-Hodgkin Lymphoma at ASCO Annual Meeting
Yahoo/BusinessWire
Sun, 06/1/14 - 11:54 am
SGN-CD19A
Seattle Genetics
non-Hodgkin's lymphoma
AbbVie Presents New Results from Studies of Investigational Oncology Compound ABT-199/GDC-0199 at the 2014 American Society of Clinical Oncology Annual Meeting
Yahoo/PR NewsWire
Sat, 05/31/14 - 10:34 am
AbbVie
ABT-199
chronic lymphocytic leukemia
leukemia
non-Hodgkin's lymphoma
Cell Therapeutics' aggressive non-hodgkin lymphoma treatment wins market access in France
Pharmaceutical Business Review
Mon, 08/19/13 - 09:54 am
non-Hodgkin's lymphoma
France
Cell Therapeutics
Pixuvri
Celgene's candidates for non-Hodgkin's lymphomas show positive results
The Fly on the Wall
Thu, 06/20/13 - 12:19 pm
Celgene
non-Hodgkin's lymphoma
Revlimid
rituximab
[video]3 Blood Cancer Drug Hopefuls in the Spotlight
Motley Fool
Thu, 06/20/13 - 07:46 am
Infinity Pharmaceuticals
JNJ
Pharmacyclics
Gilead
non-Hodgkin's lymphoma
ibrutinib
Idelalisib
IPI-145
Tiny Biotech Developing Drugs Akin To Biogen's Rituxan Seen As Potential Buyout Bet
Forbes
Mon, 05/27/13 - 08:17 pm
Biogen Idec
Rituxan
TG Therapeutics
Utuxin
TGR-1202
CLL
chronic lymphocytic leukemia
non-Hodgkin's lymphoma
Pfizer halts study of lymphoma drug unlikely to help survival
Reuters
Tue, 05/21/13 - 10:08 am
Pfizer
inotuzumab
non-Hodgkin's lymphoma
German Institute for Quality and Efficiency in Health Care (IQWiG) Publishes Dossier Evaluation within Early Benefit Assessment Process of Pixuvri (pixantrone)
Yahoo/PR Newswire
Sat, 03/2/13 - 03:56 pm
Pixuvri
non-Hodgkin B-cell lymphoma
non-Hodgkin's lymphoma
Cell Therapeutics
Boehringer Testing Copy of Rituxan in Type of Lymphoma
Bloomberg
Wed, 01/30/13 - 10:57 am
Rituxan
Boehringer Ingelheim
Roche
non-Hodgkin's lymphoma
Seattle Genetics to test possible new Adcetris use in late-stage study
Yahoo/AP
Mon, 12/10/12 - 12:04 pm
Seattle Genetics
Adcetris
non-Hodgkin's lymphoma
Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Data in CD30-Positive Non-Hodgkin Lymphomas and Other Malignancies from Multiple Presentations at ASH Annual Meeting
Yahoo/BusinessWire
Sun, 12/9/12 - 01:17 pm
Seattle Genetics
Adcetris
non-Hodgkin's lymphoma
Cell Therapeutics soars 24% on EU drug launch
Marketwatch
Tue, 09/11/12 - 01:25 pm
Europe
Cell Therapeutics
Pixuvri
non-Hodgkin's lymphoma
Pharmacyclics shares continue climb as analysts project blockbuster sales for cancer drug
Yahoo/AP
Fri, 06/8/12 - 10:06 am
Pharmacyclics
ibrutinib
non-Hodgkin's lymphoma
chronic lymphocytic leukemia
Study of Treanda shows great promise for Teva's drug
Fierce Pharma
Mon, 06/4/12 - 05:46 pm
Teva Pharmaceuticals
Treanda
ASCO
non-Hodgkin's lymphoma
J&J to Pay Pharmacyclics as Much as $975 Million in Cancer Deal
Bloomberg
Fri, 12/9/11 - 09:39 am
JNJ
Pharmacyclics
PCI-32765
non-Hodgkin's lymphoma
Spectrum Pharmaceuticals Gets Lift from FDA Action On One Of Its Cancer Treatments
Forbes
Sat, 12/3/11 - 03:50 pm
Spectrum Pharmaceuticals
Zevalin
non-Hodgkin's lymphoma
osteosarcoma
Fusilev
Pages
« first
‹ previous
1
2
3
4
next ›
last »